Point72 (Difc) LTD Oric Pharmaceuticals, Inc. Transaction History
Point72 (Difc) LTD
- $2.64 Trillion
- Q2 2025
A detailed history of Point72 (Difc) LTD transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 3,980 shares of ORIC stock, worth $45,252. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,980Holding current value
$45,252% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
146Shares Held
91.8MCall Options Held
1.03MPut Options Held
10.1K-
Nextech Invest, Ltd. Zurich, V87.16MShares$81.4 Million13.76% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$75 Million13.26% of portfolio
-
Viking Global Investors LP6.57MShares$74.7 Million0.21% of portfolio
-
Nextech Invest Ag5.29MShares$60.1 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$54.9 Million0.0% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $450M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...